Literature DB >> 18475540

Phosphoinositide hydrolysis mediated by H1 receptors in autoimmune myocarditis mice.

N Goren1, C P Leiros, L Sterin-Borda, E S Borda.   

Abstract

Stimulation of phosphoinositide hydrolysis in myocardium from autoimmune myocarditis mice by ThEA and histamine was assayed. Myocardium from autoimmune heart, but not the normal forms, specifically increased phosphoinositide turnover in the presence of histaminergic agonists. This increment was blocked by a specific H1 antagonist mepyramine and to the same extent by the phospholipase C inhibitor NCDC. By using a binding assay H1 histaminergic receptors were detected in autoimmune heart membrane preparations, but this was not observed in normal heart. These data suggest that autoimmune myocardium expressed a functional H1 receptor that could involve a distinctive mechanism operating in the disease.

Entities:  

Year:  1993        PMID: 18475540      PMCID: PMC2365419          DOI: 10.1155/S0962935193000444

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  13 in total

1.  Intraoperative kinetics and regional distribution of interleukin-6 during human liver transplantation.

Authors:  G Hamilton; G Tüchy; B Hamilton
Journal:  Transplantation       Date:  1992-10       Impact factor: 4.939

Review 2.  Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome.

Authors:  E Mor; H Solomon; J F Gibbs; M J Holman; R M Goldstein; B S Husberg; T A Gonwa; G B Klintmalm
Journal:  Semin Liver Dis       Date:  1992-02       Impact factor: 6.115

3.  Clinical value of cytokine determination for screening, differentiation, and therapy monitoring of infectious and noninfectious complications after orthotopic liver transplantation.

Authors:  T Kraus; I L Noronha; M Manner; E Klar; P Küppers; G Otto
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 4.  The regulation of expression of major histocompatibility complex products.

Authors:  P F Halloran; A Wadgymar; P Autenried
Journal:  Transplantation       Date:  1986-04       Impact factor: 4.939

5.  The influence of preservation injury on rejection in the hepatic transplant recipient.

Authors:  T K Howard; G B Klintmalm; J B Cofer; B S Husberg; R M Goldstein; T A Gonwa
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

6.  Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat.

Authors:  M Goto; Y Takei; S Kawano; S Tsuji; H Fukui; H Fushimi; Y Nishimura; T Kashiwagi; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

7.  The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation.

Authors:  D K Imagawa; J M Millis; K M Olthoff; L J Derus; D Chia; L R Sugich; M Ozawa; R A Dempsey; Y Iwaki; P J Levy
Journal:  Transplantation       Date:  1990-08       Impact factor: 4.939

8.  Intraoperative estimation of endotoxin, TNF alpha, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection.

Authors:  R Függer; G Hamilton; R Steininger; D Mirza; F Schulz; F Mühlbacher
Journal:  Transplantation       Date:  1991-08       Impact factor: 4.939

9.  Quantitative endotoxin determination in blood--chromogenic modification of the limulus amebocyte lysate test.

Authors:  D Berger; E Marzinzig; M Marzinzig; H G Beger
Journal:  Eur Surg Res       Date:  1988       Impact factor: 1.745

10.  Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients.

Authors:  G Hamilton; M Prettenhofer; A Zommer; S Hofbauer; P Götzinger; F X Gnant; R Függer
Journal:  Immunobiology       Date:  1991-08       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.